Christopher D. King

ORCID: 0000-0001-9827-8745
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pain Mechanisms and Treatments
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Pain Management and Placebo Effect
  • Stress Responses and Cortisol
  • Inflammatory mediators and NSAID effects
  • Asthma and respiratory diseases
  • Musculoskeletal pain and rehabilitation
  • Suicide and Self-Harm Studies
  • Pharmaceutical studies and practices
  • Mental Health Research Topics
  • Synthesis and Biological Evaluation
  • Mental Health Treatment and Access
  • Optimism, Hope, and Well-being
  • Neuroscience and Neuropharmacology Research
  • Heart Rate Variability and Autonomic Control
  • Spinal Cord Injury Research
  • Child and Adolescent Psychosocial and Emotional Development
  • Pharmacogenetics and Drug Metabolism
  • Chemical Synthesis and Analysis
  • Resilience and Mental Health
  • Sleep and related disorders
  • Neuropeptides and Animal Physiology
  • Exercise and Physiological Responses
  • Functional Brain Connectivity Studies
  • Epigenetics and DNA Methylation

Emory University
2020-2024

Franciscan Hospital for Children
2019-2021

Cincinnati Children's Hospital Medical Center
2021

University of Kentucky
2021

McLean Hospital
2018-2021

Arena Pharmaceuticals (United States)
2018-2019

Harvard University
2018-2019

University of Florida
2005-2014

Florida College
2012-2014

Bristol-Myers Squibb (Germany)
2012

Objective To identify psychological profiles in persons with knee osteoarthritis (OA) and to determine the relationship between these specific pain sensory characteristics, including temporal summation conditioned modulation. Methods Individuals OA (n = 194) completed psychological, health, assessments. Hierarchical cluster analysis was used derive that were compared across several clinical pain/disability experimental responses. Results Cluster 1 had high optimism low negative affect,...

10.1002/acr.22070 article EN Arthritis Care & Research 2013-07-16

Historically, researchers have proposed higher-order factors to explicate the structure of psychopathology, including Externalizing, Internalizing, Fear, Distress, Thought Disorder, and a general factor. Despite extensive research in this domain, underlying psychopathology remains unresolved. Here, we examine several issues adjudicating among structural models psychopathology. Using simulations analyses extant literature, contrast model-based reliability alternative highlight shortcomings...

10.1177/21677026221144256 article EN Clinical Psychological Science 2023-06-09

The potent 5-lipoxygenase-activating protein (FLAP) inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropionic acid 11cc is described (AM803, now GSK2190915). Building upon AM103 (1) (Hutchinson et al. J. Med Chem.2009, 52, 5803-5815; Stock Bioorg. Med. Chem. Lett. 2010, 20, 213-217; Lett.2010, 4598-4601), SAR studies centering around the pyridine moiety led to discovery of compounds that exhibit significantly...

10.1021/jm2008369 article EN Journal of Medicinal Chemistry 2011-11-07

Background: Rodent models of orofacial pain typically use methods adapted from manipulations to hind paw; however, limitations these include animal restraint and subjective assessments behavior by the experimenter. In contrast methods, assessment operant responses painful stimuli has been shown overcome expand breadth interpretation behavioral responses. current study, we used an model based on a reward-conflict paradigm assess nociceptive in three strains mice (SKH1-Hr hr , C57BL/6J, TRPV1...

10.1186/1744-8069-4-43 article EN cc-by-nc Molecular Pain 2008-01-01

The potent and selective 5-lipoxygenase-activating protein leukotriene synthesis inhibitor 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (11j) is described. Lead optimization was designed to afford compounds with superior in vitro vivo inhibition of addition having excellent pharmacokinetics safety rats dogs. key structural features these new are incorporation heterocycles on the indole N-benzyl substituent...

10.1021/jm900945d article EN Journal of Medicinal Chemistry 2009-09-09

To describe and understand varieties characteristics of sensitization contributing to hyperalgesia in participants with chronic pain conditions.

10.1097/ajp.0b013e318287aac7 article EN Clinical Journal of Pain 2013-04-26

Age-dependent changes in thermal sensitivity were evaluated with reflex- and operant-based assessment strategies animals ranging age from 8 to 32 months. The impact of inflammatory injury on was also determined different ages. results showed that operant measures escape behavior are needed demonstrate significant across the life span female Long-Evans rats. Increased both heat (44.5°C) cold (1.5°C–15°C) observed for older animals, a greater relative increase cold. Physical performance...

10.1093/gerona/glq024 article EN The Journals of Gerontology Series A 2010-02-25

In mammals, somatosensory input activates feedback and feed-forward inhibitory circuits within the spinal cord dorsal horn to modulate sensory processing thereby affecting perception by brain. Conventionally, activity evoked is believed be driven glutamate, principle excitatory neurotransmitter in primary afferent fibers. Substance P (SP), prototypic neuropeptide released from fibers horn, regarded as a pain substance mammalian system due its action on nociceptive projection neurons. Here we...

10.1186/1744-8069-1-20 article EN cc-by-nc Molecular Pain 2005-01-01

To assess the pharmacokinetics, pharmacodynamics, safety and tolerability of 5-lipoxygenase-activating protein inhibitor, GSK2190915, after oral dosing in two independent phase I studies, one Western European Japanese subjects, utilizing different formulations.Western subjects received single (50-1000 mg) or multiple (10-450 doses GSK2190915 placebo a dose-escalating manner. three four (10-200 plus once period crossover design. Blood samples were collected for concentrations blood urine to...

10.1111/j.1365-2125.2012.04386.x article EN British Journal of Clinical Pharmacology 2012-07-19

10.1007/s10488-019-00982-7 article EN Administration and Policy in Mental Health and Mental Health Services Research 2019-10-04

Few studies in healthy subjects have examined the neuroimmune responses associated with specific experimental pain stimuli, while none has measured multiple biomarkers simultaneously. The aim of present study was to compare neuro-immune following two common stimuli: cold pressor test (CPT) and focal heat (FHP). Eight adults participated counterbalanced sessions FHP or CPT continuous ratings blood sampling before 30 minutes after sessions. Despite similar intensity (FHP = 42.2 ± 15.3; 44.5...

10.1155/2012/538739 article EN cc-by Pain Research and Treatment 2012-11-20

Background The review of collateral information is an essential component patient care. Although this standard practice, minimal research has been done to quantify collection and understand how translates clinical decision making. To address this, we developed piloted a novel measure (the McLean Collateral Information Clinical Actionability Scale [M-CICAS]) evaluate the types number sources viewed resulting actions made in psychiatric setting. Objective This study aims test feasibility...

10.2196/25050 article EN cc-by JMIR Mental Health 2021-01-14
Coming Soon ...